🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 47 of 200 · A–Z by INN

  1. cycloserine

    SEROMYCIN Sana Biotechnology

    ORAL FDA: approved

  2. cyclosilicate

    NMPA: clinical trials

  3. cyclosporine

    CYCLOSPORINE Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved · NMPA: clinical trials

  4. cyclothiazide

    FLUIDIL

    ORAL FDA: approved

  5. cycrimine hydrochloride

    PAGITANE

    ORAL FDA: approved

  6. cyh33

    NMPA: clinical trials

  7. cyproheptadine hydrochloride

    CYPROHEPTADINE HYDROCHLORIDE Beam Therapeutics

    ORAL FDA: approved

  8. cyproterone

    CYPROTERONE SANDOZ Amdipharm Mercury (Australia) Pty Limited

    TGA: approved

  9. cysteamine bitartrate

    CYSTAGON

    ORAL FDA: approved

  10. cysteamine hydrochloride

    CYSTADROPS

    OPHTHALMIC FDA: approved

  11. cysteine hydrochloride

    CYSTEINE HYDROCHLORIDE

    INJECTION FDA: approved

  12. cytarabine

    PFIZER AUSTRALIA PTY LTD Pfizer Australia Pty Ltd

    INJECTION FDA: approved · EMA: withdrawn · TGA: approved · NMPA: clinical trials

    L01BC01

  13. cytokine-induced

    NMPA: clinical trials

  14. cytoxan

    NMPA: clinical trials

  15. da-

    NMPA: clinical trials

  16. dabigatran

    ARX-DABIGATRAN Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  17. dabigatran etexilate

    DABIGATRAN ETEXILATE ACCORD Teva Pharma GmbH

    EMA: approved

    B01AE07

  18. dabigatran etexilate mesylate

    DABIGATRAN ETEXILATE MESYLATE Teva Pharma GmbH

    ORAL FDA: approved

  19. dabigatran etexilate methanesulfonate

    PRADAXA

    PMDA: approved

  20. dabrafenib

    TAFINLAR Novartis Pharmaceuticals

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01EC02

  21. dabrafenib mesilate

    TAFINLAR INITIAL APPROVAL

    PMDA: approved

  22. dabrafenib mesylate

    TAFINLAR

    ORAL FDA: approved

  23. dacarbazine

    DACARBAZINE

    INJECTION FDA: approved · NMPA: clinical trials

  24. daclatasvir

    DAKLINZA

    EMA: unknown

    J05AP07

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources